Literature DB >> 16274416

CRT-D therapy in patients with left ventricular dysfunction and atrial fibrillation.

Frank Pelosi1, Fred Morady.   

Abstract

The number of patients with atrial fibrillation and congestive heart failure has steadily increased in the United States. The presence of atrial fibrillation increases morbidity and mortality for patients with left ventricular dysfunction. The emergence of cardiac resynchronization therapy to improve symptoms and survival from congestive heart failure may provide benefits for those with atrial fibrillation; we review the pathophysiology of atrial fibrillation in the presence of left ventricular dysfunction and the promise of cardiac resynchronization therapy to improve symptoms for the for these patients.

Entities:  

Mesh:

Year:  2005        PMID: 16274416      PMCID: PMC6932330          DOI: 10.1111/j.1542-474X.2005.00072.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  24 in total

1.  Spontaneous conversion of atrial fibrillation in the setting of biventricular pacing.

Authors:  Julia H Indik
Journal:  Cardiol Rev       Date:  2004 Jan-Feb       Impact factor: 2.644

2.  Spontaneous conversion of permanent atrial fibrillation into stable sinus rhythm after 17 months of biventricular pacing.

Authors:  Klaus Malinowski
Journal:  Pacing Clin Electrophysiol       Date:  2003-07       Impact factor: 1.976

3.  Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure.

Authors:  Maarten P van den Berg; Geert Tjeerdsma; Pieter Jan de Kam; Frans Boomsma; Harry J G M Crijns; Dirk J van Veldhuisen
Journal:  Eur J Heart Fail       Date:  2002-06       Impact factor: 15.534

4.  Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation.

Authors:  Sander G Molhoek; Jeroen J Bax; Gabe B Bleeker; Eric Boersma; L van Erven; Paul Steendijk; Ernst E van der Wall; Martin J Schalij
Journal:  Am J Cardiol       Date:  2004-12-15       Impact factor: 2.778

5.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

6.  Epidemiology and determinants of outcome of admissions for atrial fibrillation in the United States from 1996 to 2001.

Authors:  Farhat Khairallah; Rana Ezzedine; Leonard I Ganz; Barry London; Samir Saba
Journal:  Am J Cardiol       Date:  2004-08-15       Impact factor: 2.778

7.  Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators.

Authors:  P C Deedwania; B N Singh; K Ellenbogen; S Fisher; R Fletcher; S N Singh
Journal:  Circulation       Date:  1998-12-08       Impact factor: 29.690

8.  Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention.

Authors:  Wendy A Wattigney; George A Mensah; Janet B Croft
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

9.  Trends in heart failure incidence and survival in a community-based population.

Authors:  Véronique L Roger; Susan A Weston; Margaret M Redfield; Jens P Hellermann-Homan; Jill Killian; Barbara P Yawn; Steven J Jacobsen
Journal:  JAMA       Date:  2004-07-21       Impact factor: 56.272

10.  Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.

Authors: 
Journal:  Am Heart J       Date:  2002-10       Impact factor: 4.749

View more
  1 in total

1.  Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients.

Authors:  Kenneth C Bilchick; Sandeep Kamath; John P DiMarco; George J Stukenborg
Journal:  Circulation       Date:  2010-11-01       Impact factor: 29.690

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.